# Cogent Biosciences, Inc.: Form 8-K, filed Jun 11, 2026

- Company: [Cogent Biosciences, Inc.](/companies/cogt.md) (CIK 1622229)
- Form: 8-K
- Filed: 2026-06-11
- Accepted by EDGAR: Jun 11, 2026, 16:15 ET
- Period: 2026-06-09
- Accession: 0001193125-26-267566
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1622229/000119312526267566/d100263d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1622229/000119312526267566/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1622229/000119312526267566/d100263d8k.htm

Filed Jun 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-267566. Last ingested by Listed: Nov 5, 2026, 18:48 ET. No prices; not investment advice.
